| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 5.161 | 12.631 | 14.425 | 20.802 | 16.019 | 9.604 | 8.123 | 16.141 | 44.201 |
| Total Income - EUR | - | 5.161 | 12.631 | 14.425 | 20.802 | 18.020 | 9.604 | 8.123 | 16.141 | 44.201 |
| Total Expenses - EUR | - | 8.977 | 13.111 | 10.687 | 12.727 | 7.877 | 2.072 | 1.792 | 10.785 | 36.663 |
| Gross Profit/Loss - EUR | - | -3.816 | -479 | 3.737 | 8.076 | 10.143 | 7.532 | 6.332 | 5.356 | 7.538 |
| Net Profit/Loss - EUR | - | -3.971 | -858 | 3.304 | 7.459 | 9.702 | 7.361 | 6.176 | 4.422 | 6.252 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Osteomedica Dxa Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 25.352 | 17.784 | 10.450 | 3.411 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 215 | 410 | 2.113 | 7.538 | 10.246 | 7.668 | 6.624 | 5.471 | 7.033 |
| Inventories | - | 0 | 0 | 232 | 0 | 0 | 10 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 5.982 | 0 | 4.381 | 2.761 | 0 | 4.155 |
| Cash | - | 215 | 410 | 1.881 | 1.556 | 10.246 | 3.278 | 3.863 | 5.471 | 2.878 |
| Shareholders Funds | - | -3.926 | -4.718 | -1.327 | 6.157 | 9.873 | 7.410 | 6.225 | 5.385 | 6.300 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 29.494 | 22.912 | 13.890 | 6.394 | 373 | 259 | 399 | 86 | 733 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Osteomedica Dxa Srl